Natalizumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3618 publications
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.
Journal: Journal of medical economics
Published: June 24, 2026
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 23, 2026
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: June 23, 2026
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis.
Journal: Journal of medical economics
Published: June 21, 2026
Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 11, 2026
Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.
Journal: Neurology
Published: May 29, 2026
Real-world experience with rituximab for multiple sclerosis treatment in a Brazilian tertiary center.
Journal: Arquivos de neuro-psiquiatria
Published: May 18, 2026
Anti-JCV antibody seroprevalence and testing practices in multiple sclerosis patients considered for natalizumab therapy: a retrospective study from King Saud Medical City, Riyadh, Saudi Arabia.
Journal: Multiple sclerosis and related disorders
Published: May 12, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology
Published: May 05, 2026
Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review.
Journal: Journal of clinical medicine
Published: May 03, 2026
Last Updated: 06/30/2026